Dow Up 0.09% Nasdaq Down 0.02%

Idera Pharmaceuticals, Inc. (IDRA)

-NasdaqCM
2.88 Aug 27, 4:00PM EDT
Prev Close:2.88
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:7.00
Beta:3.29
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:1.51 - 6.87
Volume:0
Avg Vol (3m):1,455,330
Market Cap:241.25M
P/E (ttm):N/A
EPS (ttm):-0.47
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IDRA

Comparison

Symbol% ChgMkt Cap
IDRA 0.00%241.25M
DVAX373.29M
PFE186.99B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4,639.40
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.45
Quarterly EPS Est (Sep-14) :-0.11
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors (TLRs) in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback